|
EIF2AK4 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.427660E-02 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.563200E-03 |
| Normal-vs-AfricanAmerican |
7.562000E-02 |
| Normal-vs-Asian |
2.007000E-01 |
| Caucasian-vs-AfricanAmerican |
4.583000E-03 |
| Caucasian-vs-Asian |
6.715900E-03 |
| AfricanAmerican-vs-Asian |
2.628600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.543200E-03 |
| Normal-vs-Female |
2.134300E-02 |
| Male-vs-Female |
1.194180E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.729750E-02 |
| Normal-vs-Age(41-60Yrs) |
1.782170E-02 |
| Normal-vs-Age(61-80Yrs) |
1.701850E-02 |
| Normal-vs-Age(81-100Yrs) |
1.303000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.705200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.631800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.654200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.657400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.220500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.989510E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
5.088000E-02 |
| Normal-vs-Pheochromocytoma |
1.273870E-02 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.296500E-02 |
| Paraganglioma-vs-Pheochromocytoma |
9.516400E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.431800E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.602400E-01 |
|
|
